BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27460253)

  • 1. Sickle Cell Imaging Flow Cytometry Assay (SIFCA).
    Fertrin KY; Samsel L; van Beers EJ; Mendelsohn L; Kato GJ; McCoy JP
    Methods Mol Biol; 2016; 1389():279-92. PubMed ID: 27460253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease.
    van Beers EJ; Samsel L; Mendelsohn L; Saiyed R; Fertrin KY; Brantner CA; Daniels MP; Nichols J; McCoy JP; Kato GJ
    Am J Hematol; 2014 Jun; 89(6):598-603. PubMed ID: 24585634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sickling in vitro by three purine-based antiviral agents: an approach to the treatment of sickle cell disease.
    DeBellis RH; Chen BX; Erlanger BF
    Blood Cells Mol Dis; 2003; 31(2):286-90. PubMed ID: 12972037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic fragility of normal and sickle haemoglobin containing red blood cells.
    Dash BP; Mittra A; Kar BC
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):267-9. PubMed ID: 10365325
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging flow cytometry for the study of erythroid cell biology and pathology.
    Samsel L; McCoy JP
    J Immunol Methods; 2015 Aug; 423():52-9. PubMed ID: 25858229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of sickling process due to turbulent blood flow.
    Stein PD; Sabbah HN; Mandal AK
    J Appl Physiol; 1976 Jan; 40(1):60-6. PubMed ID: 1248984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes.
    Presley TD; Perlegas AS; Bain LE; Ballas SK; Nichols JS; Sabio H; Gladwin MT; Kato GJ; Kim-Shapiro DB
    Hemoglobin; 2010; 34(1):24-36. PubMed ID: 20113285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single cell laser light scattering spectroscopy in a flow cell: repeated sickling of sickle red blood cells.
    Peetermans JA; Nishio I; Ohnishi ST; Tanaka T
    Biochim Biophys Acta; 1987 Dec; 931(3):320-5. PubMed ID: 3676348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homoserine inhibition of in vitro sickling of erythrocytes.
    Kang SS; Benjamin G
    Exp Mol Pathol; 1975 Apr; 22(2):220-4. PubMed ID: 1116571
    [No Abstract]   [Full Text] [Related]  

  • 12. Theoretical Simulation of Red Cell Sickling Upon Deoxygenation Based on the Physical Chemistry of Sickle Hemoglobin Fiber Formation.
    Dunkelberger EB; Metaferia B; Cellmer T; Henry ER
    J Phys Chem B; 2018 Dec; 122(49):11579-11590. PubMed ID: 30179501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise and hypoxia increase sickling in venous blood from an exercising limb in individuals with sickle cell trait.
    Martin TW; Weisman IM; Zeballos RJ; Stephenson SR
    Am J Med; 1989 Jul; 87(1):48-56. PubMed ID: 2741981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease.
    Harrod VL; Howard TA; Zimmerman SA; Dertinger SD; Ware RE
    Exp Hematol; 2007 Feb; 35(2):179-83. PubMed ID: 17258066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual variability in response to a single sickling event for normal, sickle cell, and sickle trait erythrocytes.
    Tarasev M; Muchnik M; Light L; Alfano K; Chakraborty S
    Transl Res; 2017 Mar; 181():96-107. PubMed ID: 27728824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sickle cell anemia and the affinity of the blood for oxygen].
    Pocidalo JJ; Sinet M
    C R Seances Soc Biol Fil; 1979; 173(2):303-13. PubMed ID: 159755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmotic effects of protein polymerization: analysis of volume changes in sickle cell anemia red cells following deoxy-hemoglobin S polymerization.
    Lew VL; Bookchin RM
    J Membr Biol; 1991 May; 122(1):55-67. PubMed ID: 1875401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia.
    Strader MB; Liang H; Meng F; Harper J; Ostrowski DA; Henry ER; Shet AS; Eaton WA; Thein SL; Alayash AI
    Bioconjug Chem; 2019 Mar; 30(3):568-571. PubMed ID: 30794381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of anthocyanin extracts from Justicia secunda Vahl on the solubility of haemoglobin S and membrane stability of sickle erythrocytes.
    Mpiana PT; Ngbolua KN; Bokota MT; Kasonga TK; Atibu EK; Tshibangu DS; Mudogo V
    Blood Transfus; 2010 Oct; 8(4):248-54. PubMed ID: 20967165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Globin sleeping beauty transposon reduces red blood cell sickling in a patient-derived CD34(+)-based in vitro model.
    Sjeklocha LM; Wong PY; Belcher JD; Vercellotti GM; Steer CJ
    PLoS One; 2013; 8(11):e80403. PubMed ID: 24260386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.